People_
Associate Professor Phoebe Williams
BSc(Psychology) BCom (Development Economics) MBBS(Hons) DCH MSc (Global Health Science) FRACP DPhil
Senior Lecturer, NHMRC Fellow. School of Public Health, Faculty of Medicine
Details
Member of Sydney Southeast Asia Centre
Infection and Immunological Conditions, Reproductive, Maternal and Child Health
Publications
Expand all
Journals
- Williams, A., Coombs, G., Bell, J., Daley, D., Mowlaboccus, S., Bryant, P., Campbell, A., Cooley, L., Iredell, J., Irwin, A., Kesson, A., Williams, P., et al (2025). Antimicrobial resistance in Staphylococcus aureus and Enterococci spp. isolates from bloodstream infections in Australian children, 2013 – 2021. Journal of the Pediatric Infectious Diseases Society, 14(2), piae110. [More Information]
- Jayasinghe, S., Williams, P., Macartney, K., Crawford, N., Blyth, C. (2025). Assessing the impact of pneumococcal conjugate vaccine immunisation schedule change from 3+0 to 2+1 in Australian children: A retrospective observational study (In Press). Clinical Infectious Diseases, 80(1), 207-214. [More Information]
- Williams, A., Coombs, G., Bell, J., Daley, D., Mowlaboccus, S., Bryant, P., Campbell, A., Cooley, L., Iredell, J., Irwin, A., et al (2024). Antimicrobial resistance in Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa isolates from bloodstream infections in Australian children, 2013-2021. Journal of the Pediatric Infectious Diseases Society, , piae111.
show 52 more
Expand all
2025
- Williams, A., Coombs, G., Bell, J., Daley, D., Mowlaboccus, S., Bryant, P., Campbell, A., Cooley, L., Iredell, J., Irwin, A., Kesson, A., Williams, P., et al (2025). Antimicrobial resistance in Staphylococcus aureus and Enterococci spp. isolates from bloodstream infections in Australian children, 2013 – 2021. Journal of the Pediatric Infectious Diseases Society, 14(2), piae110. [More Information]
- Jayasinghe, S., Williams, P., Macartney, K., Crawford, N., Blyth, C. (2025). Assessing the impact of pneumococcal conjugate vaccine immunisation schedule change from 3+0 to 2+1 in Australian children: A retrospective observational study (In Press). Clinical Infectious Diseases, 80(1), 207-214. [More Information]
2024
- Williams, A., Coombs, G., Bell, J., Daley, D., Mowlaboccus, S., Bryant, P., Campbell, A., Cooley, L., Iredell, J., Irwin, A., et al (2024). Antimicrobial resistance in Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa isolates from bloodstream infections in Australian children, 2013-2021. Journal of the Pediatric Infectious Diseases Society, , piae111.
- Moore, N., Ashley, E., Dickson, B., Douangnouvong, A., Panyaviseth, P., Turner, P., Williams, P. (2024). Antimicrobial susceptibility profiles of invasive bacterial infections among children from low- and middle-income countries in the Western Pacific Region (WPRO) – a systematic review and meta-analysis. The Lancet Regional Health. Western Pacific, 51, 101177. [More Information]
- Williams, A., Coombs, G., Bell, J., Daley, D., Mowlaboccus, S., Bryant, P., Campbell, A., Cooley, L., Iredell, J., Irwin, A., Kesson, A., Williams, P., et al (2024). Australian Group on Antimicrobial Research surveillance outcome programs – bloodstream infections and antimicrobial resistance patterns from patients less than 18 years of age. January 2020-December 2021. Communicable Diseases Intelligence, 48. [More Information]
show 10 more
2023
- Purcell, R., Yeoh, D., Bowen, A., Britton, P., Carr, J., Chen, M., Cheung, K., Clark, J., Irwin, A., Lai, T., Williams, P., et al (2023). A multicentre, retrospective audit of fosfomycin use for urinary tract infections in Australian children and adolescents. Journal of Antimicrobial Chemotherapy, 78(7), 1616-1621. [More Information]
- Ramsay, J., Jones, M., Vande More, A., Hunt, S., Williams, P., Messer, M., Wood, N., Macartney, K., Lee, F., Britton, W., Snelling, T., Caterson, I. (2023). A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study). Vaccine, 41(48), 7250-7258. [More Information]
- Williams, P., Howard-Jones, A., Butters, C., Koirala, A., Britton, P., Duguid, R., Wijeratne, P., Johnson, N., Jayasinghe, S. (2023). Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2. Pediatric Infectious Disease Journal, 42(9), E341-E342. [More Information]
show 4 more
2022
- Williams, P., Bartlett, A., Palasanthiran, P., McMullan, B. (2022). A not so innocuous playground fall: Lymphocutaneous nocardiosis in an immunocompetent boy. Archives of Disease in Childhood, 107(3), 257-258. [More Information]
- Williams, P., Qazi, S., Agarwal, R., Velaphi, S., Bielicki, J., Nambiar, S., Giaquinto, C., Bradley, J., Noel, G., Ellis, S., et al (2022). Antibiotics needed to treat multidrug-resistant infections in neonates. Bulletin of the World Health Organization, 100(12), 797-807. [More Information]
- Williams, P., Koirala, A., Saravanos, G., Lopez, L., Glover, C., Sharma, K., Williams, T., Carey, E., Shaw, N., Dickens, E., Macartney, K., Wood, N., Britton, P., et al (2022). COVID-19 in New South Wales children during 2021: severity and clinical spectrum. Medical Journal of Australia, 217(6), 303-310. [More Information]
show 6 more
2021
- Williams, P., Marais, B., Isaacs, D., Preisz, A. (2021). Ethical considerations regarding the effects of climate change and planetary health on children. Journal of Paediatrics and Child Health, 57(11), 1775-1780. [More Information]
- Williams, P., Bradley, J., Roilides, E., Olson, L., Kaplan, S., Lutsar, I., Giaquinto, C., Benjamin, D., Sharland, M. (2021). Harmonising regulatory approval for antibiotics in children. The Lancet Child and Adolescent Health, 5(2), 96-98. [More Information]
- Williams, P., Bartlett, A., Howard-Jones, A., McMullan, B., Khatami, A., Britton, P., Marais, B. (2021). Impact of climate change and biodiversity collapse on the global emergence and spread of infectious diseases. Journal of Paediatrics and Child Health, 57(11), 1811-1818. [More Information]
show 2 more
2020
- Williams, P. (2020). Potential of fosfomycin in treating multidrug-resistant infections in children. Journal of Paediatrics and Child Health, 56(6), 864-872. [More Information]
- Williams, P., Howard-Jones, A., Hsu, P., Palasanthiran, P., Gray, P., McMullan, B., Britton, P., Bartlett, A. (2020). SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology, 52(7), 801-808. [More Information]
- Bartlett, A., Williams, P., Jantarabenjakul, W., Kerr, S. (2020). State of the Mind: Growing up with HIV. Paediatric Drugs, 22(5), 511-524. [More Information]
show 1 more
2019
- Williams, P., Waichungo, J., Gordon, N., Sharland, M., Murunga, S., Kamau, A., Berkley, J. (2019). The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria. Journal of Medical Microbiology, 68(5), 711-719. [More Information]
2018
- Williams, P., Berkley, J. (2018). Grading antimicrobial susceptibility data quality: room for improvement - Authors' reply. The Lancet Infectious Diseases, 18(6), 604-605. [More Information]
- Williams, P., Berkley, J. (2018). Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatrics and International Child Health, 38(sup1), S50-S65. [More Information]
- Williams, P., Berkley, J. (2018). Guidelines for the treatment of paediatric cholera infection: A systematic review of the evidence. Paediatrics and International Child Health, 38(sup1), S16-S31. [More Information]
show 2 more
2017
- Williams, P., Isaacs, D., Berkley, J. (2017). Antimicrobial resistance among children in sub-Saharan Africa. The Lancet Infectious Diseases, 18(2), e33-e44. [More Information]
- Williams, P. (2017). The reality of the mortality statistics of the nurses` strike in Kenya. The Lancet, 390(10094), 551. [More Information]
2014
- Williams, P., Wegner, E., Ziegler, D. (2014). Outcomes in multifocal neuroblastoma as part of the neurocristopathy syndrome. Pediatrics, 134(2). [More Information]
2011
- Jones, L., Akugizibwe, P., Clayton, M., Amon, J., Sabin, M., Bennett, R., Williams, P., Hirnschall, G., et al (2011). Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Current HIV Research, 9(6), 416-428. [More Information]
- Granich, R., Kahn, J., Bennett, R., Holmes, C., Garg, N., Serenata, C., Williams, P., Williams, B., et al (2011). Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PloS One, 7(2), e30216. [More Information]
- Williams, P. (2011). What will it take to stop the needless deaths of millions of women and children each year? Journal of Paediatrics and Child Health, 47(5), 249-256. [More Information]
2010
- Granich, R., Akolo, C., Gunneberg, C., Getahun, H., Williams, P., Williams, B. (2010). Prevention of tuberculosis in people living with HIV. Clinical Infectious Diseases, 50(Suppl 3), S215-S222. [More Information]
2009
- Williams, P., Martina, A., Cumming, R., Hall, J. (2009). Malaria Prevention in Sub-Saharan Africa: A Field Study in Rural Uganda. Journal of Community Health, 34(4), 288-294. [More Information]
2007
- Williams, P. (2007). Reaching out with a Hand of Help. Medical Journal of Australia, 187(11-12), 681-683. [More Information]
Selected Grants
2024
- Evaluating the infant microbiome to reduce the mortality burden of antibiotic- resistant neonatal infections, Williams P, Sydney Southeast Asia Centre/SSEAC Incubator Program
2023
- Rewarding Research 2024, Williams P, Faculty of Medicine and Health/FMH Rewarding Research Success
- ACORN - A clinically-oriented antimicrobial resistance infection surveillance network, Harrison M, Williams P, Sydney Institute for Infectious Diseases (Sydney ID)/Sydney ID Seed Grants
- Improving the management of lower respiratory tract infections in children in Sri Lanka: An education program incorporating the evaluation of an algorithm to prompt judicious prescribing to reduce antimicrobial resistance, whilst understanding the burden o, Williams P, Dickson B, International Society of Antimicrobial Chemotherapy/Project Grant
- Learning health systems approach to the diagnosis and management of lower respiratory tract infections in children, Fathima P, Wu Y, Williams P, Jayasinghe S, Baker J, Department of Health and Aged Care (Federal)/Early to Mid-Career Researchers
- Optimising the treatment of antibiotic resistant urinary tract infections in children: The FOSUTI Trial, Williams P, Britton P, Bakar K, Snelling T, Totterdell J, Howell M, McKinn S, Department of Health and Aged Care (Federal - administered by NHMRC)/2021 Clinical Trials Activity
show more
Further Publications
- Bertsgnolio, S., Dobreva, Z., Centner, C. M., Olaru, I. D., Dona, D., Burzo, S., Huttner, B., Chaillon, A., Gebreselassie, N., Wi, T., Hasso-Agopsowicz, M., et al on behalf of the WHO Research Agenda for AMR in Human Health Collaborators. (2024). WHO global research priorities for antimicrobial resistance in human health. The Lancet Microbe, 5(11), 100902. [More Information]
Further Grants
- 2023-Current: MRFF Clinical Trial Activity: Individualised dose optimisation of ganciclovir in immunocompromised children trial (‘ID MAGIC’) ($1.7m; AI)
- 2022: International Society of Antimicrobial Chemotherapy Research Grant ($20,000; CIA)
- CARES-1: Ambulatory Antibiotic Therapies for Congenial Syphilis. Freyne, B., Gwee, A., Bekker, A., Cressey, T., Putri, N., McCauley, M., Kawaza, K., Gadama, L., Frigati, L., Williams, P., et al. (2024). Bill & Melinda Gates Foundation.
Conference Proceedings
- The European Society of Paediatric Infectious Diseases (ESCMID), Barcelona, 2024. Keynote speaker: Neonatal bacteraemia surveillance.
- Indonesian PICU NICU Conference, Denpasar, 2024. Keynote speaker: (i) Management of Neonatal Late-onset Sepsis: Antibiotic choice and Stewardship considerations and (ii) Diagnosis and management of neonatal sepsis.
- World Society of Paediatric Infectious Diseases (WSPID), Durban, South Africa, 2023. Keynote address: Bridging the Global North / Global South divide in paediatric child health research
- The European Society of Paediatric Infectious Diseases (ECCMID), Copenhagen, 2023. Four accepted abstracts:
- High rates of multidrug-resistant infections in neonates with sepsis in Indonesia
- High prevalence of invasive candidiasis in neonates in Southeast Asia and the Pacific
- Neonatal sepsis in a tertiary care hospital in Sri Lanka: reflection on rising antibiotic resistance over five years
- Insufficient coverage provided by empiric antibiotic regimens for serious bacterial infections in neonates and children in south-east Asia and the Pacific
- Advancing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network Launch, 2023: Keynote address; Managing neonatal sepsis in the context of rising antimicrobial resistance.
- Australian Society of Infectious Diseases (ASID), Adelaide, 2023. The potential of the Weighted Incidence Syndrome Combination Antibiogram (WISCA) to guide clinicians in selecting efficacious and appropriate empirical regimens to treat infection.
- The European Society of Paediatric Infectious Diseases/American College of Microbiology conference on antimicrobial drug development. Young Investigator (Invited Speaker): Prioritising antibiotic developmentin children and neonates. Dublin, 2022.
- Australian and New Zealand Society for Paediatric Infectious Diseases (ANZPID). Research in the time of COVID-19. Adelaide, 2022.
- The European Society of Paediatric Infectious Diseases (ECCMID), Geneva, 2021. Invited session chair: Resistance issues with Gram-negatives from Asia and Africa.
- International Immunocompromised Host Conference (NIH-ICHS). Online, 2021. Oral presentation: HHV6 encephalitis compromising a bone marrow transplant for juvenile myelomonocytic leukaemia in a young child.
- The European Society of Paediatric Infectious Diseases (ECCMID), Paris, France, 2020. Accepted abstract (oral presentation): Safety of fosfomycin in neonates. (This conference did not proceed due to COVID-19).
- Australian and New Zealand Society of Paediatric Infectious Diseases(ANZPID), Perth, Australia, 2019. Fosfomycin: An update for Paediatric Infectious Diseases Physicians.
- The World Society of Paediatric Infectious Diseases(WSPID), Manila, Philippines, 2019. The potential of fosfomycin to treat multi-resistant organisms: Results of a safety analysis in neonatal sepsis.
- Kenyan Annual Scientific & Health Meeting(KASH Conference), Nairobi, Kenya, 2018. Fosfomycin to combat Antimicrobial Resistance.Malaria Eradication in sub-Saharan Africa: Will the calls for eradication ever be achieved? Presented atSt Cross College Colloquium, Oxford University in 2010 andGreen Templeton College, Oxford University, Globalisation & Human Welfare Conference in 2010.
In the media
https://www.theguardian.com/commentisfree/2017/jul/24/this-is-not-natural-selection-east-africa-is-in-the-grip-of-a-famine-emergency
https://www.smh.com.au/national/nsw/doctors-fear-for-children-amid-pandemic-panic-20200419-p54l62.html
https://www.smh.com.au/world/lifes-chances-set-by-geography-20091218-l5on.html
https://theconversation.com/no-we-shouldnt-worry-too-much-about-getting-covid-from-young-kids-172232
https://mojomedia.com.au/the-general-sir-john-monash-scholars-podcast-featuring-dr-phoebe-williams/